Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Circulating Derived Tissue Factor Positive Microparticles and Thrombin Generation a Promising Tool for Identifying Cases at Increased Risk of Thrombotic Complications

Patrick Van Dreden, Aurelie Rousseau, Matthieu Grusse, Grigoris Gerotziafas

Blood (2024) 144 (Supplement 1): 3889.

https://doi.org/10.1182/blood-2024-199030

Published: 2024

Journal Articles

Fibrin Clot Shields Formation in the Tumor Microenvironment, Induced By Cancer Cells' Hypercoagubility, Serves As Scaffolds for Invasion and Protection Against Anticancer Treatments

Chi Mai Huong Tran, Patrick Van Dreden, Elisabeth Mbemba, Aurelie Rousseau, Eleftheria Lefkou, Michele Sabbah, Grigoris Gerotziafas

Blood (2024) 144 (Supplement 1): 5528.

https://doi.org/10.1182/blood-2024-199040

Published: 2024

Journal Articles

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Patrick Van Dreden, Eleftheria Lefkou, Aurelie Rousseau, Kostas Sfakianoudis, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 5406.

https://doi.org/10.1182/blood-2023-188792

Published: 2023

Journal Articles

Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study

Patrick Van Dreden, Loula Papageorgiou, Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurelie Rousseau, Michele Sabbah, Matthieu Grusse, Ismail Elalamy, Elisabeth Mbemba, Meletios Athanasios Dimopoulos, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 5404.

https://doi.org/10.1182/blood-2023-187055

Published: 2023

Journal Articles

Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study

Patrick Van Dreden, Loula Papageorgiou, Eleftheria Lefkou, Despina Fotiou, Efstathios Kastritis, Evangelos Terpos, Aurelie Rousseau, Michele Sabbah, Matthieu Grusse, Elisabeth Mbemba, Ismail Elalamy, Meletios Athanasios Dimopoulos, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 1203.

https://doi.org/10.1182/blood-2023-186645

Published: 2023

Journal Articles

Leukemia Inhibitory Factor, Tissue Factor, Thrombomodulin, P-Selectine, D-Dimer, Thrombin Generation and Procoagulant Phospholipid Dependent Clotting Time Are Predictive for in Vitro Fertilization Outcome. the Prospective Roadmap-IVF Study

Eleftheria Lefkou, Panagiotis Tzonis, Kostas Sfakianoudis, Aurelie Rousseau, Ismail Elalamy, Matthieu Grusse, Elisabeth Mbemba, Patrick Van Dreden, Grigoris Gerotziafas

Blood (2023) 142 (Supplement 1): 5413.

https://doi.org/10.1182/blood-2023-186236

Published: 2023

Journal Articles

Cancer Cells and Platelets Have a Synergistic Role on the Acceleration of Clot Formation and Fibrin Polymerization. a Thromboelastometric Study

Elisabeth Mbemba, Chi Mai Tran Huong, Noemie Mourot, Mohammed Baghdadi, Ismail Elalamy, Patrick Van Dreden, Grigoris Gerotziafas

Blood (2022) 140 (Supplement 1): 11284–11285.

https://doi.org/10.1182/blood-2022-166208

Published: 2022

Journal Articles

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Fakiha Siddiqui, Priya Ray, Amir Darki, Debra Hoppensteadt, Emily Krupa, Alfonso J. Tafur, Grigoris Gerotziafas, Jawed Fareed, Manuel Monreal

Blood (2022) 140 (Supplement 1): 11214–11215.

https://doi.org/10.1182/blood-2022-165790

Published: 2022

Journal Articles

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Fakiha Siddiqui, Amir Darki, Debra Hoppensteadt, Alfonso J. Tafur, Grigoris Gerotziafas, Jawed Fareed, Manuel Monreal

Blood (2022) 140 (Supplement 1): 11211–11213.

https://doi.org/10.1182/blood-2022-165767

Published: 2022

Journal Articles

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Loula Papageorgiou, Job Harenberg, Ismail Elalamy, Grigoris Gerotziafas

Blood (2021) 138 (Supplement 1): 3213.

https://doi.org/10.1182/blood-2021-149461

Published: 2021

Journal Articles

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study

Patrick Van Dreden, Joseph Gligorov, Evangelos Terpos, Mathieu Jamelot, Michele Sabbah, Despina Fotiou, Aboubakr Ka, Joanna Charitaki, Ismail Elalamy, Tina Bagratuni, Jawed Fareed, Aurélie Rousseau, Meletios A. Dimopoulos, Grigoris Gerotziafas

Blood (2021) 138 (Supplement 1): 3207.

https://doi.org/10.1182/blood-2021-146803

Published: 2021

Journal Articles

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Patrick Van Dreden, Douglas D Fraser, Guillaume Voiriot, Aurélie Rousseau, Ismail Elalamy, Ioannis Prassas, Evangelos Terpos, Meletios A. Dimopoulos, Matthieu Grusse, Grigoris Gerotziafas

Blood (2021) 138 (Supplement 1): 2121.

https://doi.org/10.1182/blood-2021-146483

Published: 2021

Journal Articles

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Loula Papageorgiou, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Matthieu Grusse, Ismail Elalamy, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2020) 136 (Supplement 1): 4.

https://doi.org/10.1182/blood-2020-139424

Published: 2020

Journal Articles

Throly Score Successfully Classifies Hodgkin Lymphoma Patients at Risk of Thromboembolic Complication

Darko Antic, Vladimir Otasevic, Sven Borchmann, Horst Muller, Vojin Vukovic, Vladislava Djurasinovic, Kristina Tomic, Biljana Mihaljevic, Grigoris Gerotziafas, MD PhD, Andreas Engert, MD, Jawed Fareed, PhD

Blood (2020) 136 (Supplement 1): 8.

https://doi.org/10.1182/blood-2020-141367

Published: 2020

Journal Articles

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Grigoris Gerotziafas, MD PhD, Patrick Van Dreden, PhD, Loula Papageorgiou, Theodoros N Sergentanis, MD PhD, Meletios-Athanasios Dimopoulos, Ismail Elalamy, MD PhD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-136528

Published: 2020

Journal Articles

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Loula Papageorgiou, Despina Fotiou, BMBS, MA, Patrick Van Dreden, PhD, Laurent Garderet, MD PhD, Meletios A. Dimopoulos, MD, Ismail Elalamy, MD PhD, Mohamad Mohty, MD PhD, Grigoris Gerotziafas, MD PhD

Blood (2019) 134 (Supplement_1): 1913.

https://doi.org/10.1182/blood-2019-126954

Published: 2019

Journal Articles

Decreased Thrombin Generation Potential in Lymphoma Patients Is Associated with Increased D-Dimer, CRP, Vwf and TNF-α. Interrelationship between Thrombogenesis and Inflammation

Fakiha Siddiqui, Emily Bontekoe, Darko Antic, PhD, Debra Hoppensteadt, PhD, Grigoris Gerotziafas, MD PhD, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 5239.

https://doi.org/10.1182/blood-2019-128440

Published: 2019

NARROW

Circulating Derived Tissue Factor Positive Microparticles and Thrombin Generation a Promising Tool for Identifying Cases at Increased Risk of Thrombotic Complications

Fibrin Clot Shields Formation in the Tumor Microenvironment, Induced By Cancer Cells' Hypercoagubility, Serves As Scaffolds for Invasion and Protection Against Anticancer Treatments

The Procoagulant Phospholipid Dependent Clotting Time and the Initiation Phase of Thrombin Generation Test Are Mandatory for the Evaluation of the Risk for Severe Early Onset Preeclampsia

Evaluation of Clinical Risk Factors and Thrombosis-Related Biomarkers in Newly Diagnosed Patients with Multiple Myeloma at Risk for Cancer-Associated Thrombosis. the Observational Roadmat-CAT-MM Study

Prothrombotic Profile in Patients with Active Multiple Myeloma and the Impact of Immunomodulators: The Roadmap-MM Study

Leukemia Inhibitory Factor, Tissue Factor, Thrombomodulin, P-Selectine, D-Dimer, Thrombin Generation and Procoagulant Phospholipid Dependent Clotting Time Are Predictive for in Vitro Fertilization Outcome. the Prospective Roadmap-IVF Study

Cancer Cells and Platelets Have a Synergistic Role on the Acceleration of Clot Formation and Fibrin Polymerization. a Thromboelastometric Study

Elevated Thrombin Generation Biomarkers and Their Relevance with Decreased Thrombin Generation Potential in Patients with Pulmonary Embolism

Amplified Thrombo-Inflammatory Biomarkers in Pulmonary Embolism with Augmented Responses in Von-Willebrand Factor, Microparticles and Interleukin-6 in Patients with Cancer

Analysis of Inter-Observer Agreement of Adjudication of Colors of Pad Colors of Doac Dipstick to Determine Presence or Absence of Direct Oral Anticoagulants in Outpatients' Urine Samples

Prospective Assessment of Biomarkers of Hypercoagulability in Oncological Patients and Healthcare Workers Following Vaccination Against Sars-Cov-2 with the mRNA Vaccine. the Roadmap-COVID-19-Vaccin Study

The Compass-COVID19-ICU Study: Identification of Factors to Predict the Risk of Intubation and Mortality in Patients with Severe COVID-19

Stratification of Vascular Profile in Multiple Myeloma Patients Using Thrombin Generation Test

Throly Score Successfully Classifies Hodgkin Lymphoma Patients at Risk of Thromboembolic Complication

Derivation and Validation of a Predictive Score for Disease Worsening Inpatients with COVID-19

Hypercoagulability Biomarkers in a New Score Linked to Treatment Resistance for Multiple Myeloma Patients. the Roadmap-MM Study

Decreased Thrombin Generation Potential in Lymphoma Patients Is Associated with Increased D-Dimer, CRP, Vwf and TNF-α. Interrelationship between Thrombogenesis and Inflammation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only